Last edition
News about Biotechnology
IBA and Shreeji Sign Multi-Site Deal to Deploy Four Cyclotrons Across India
Ion Beam Applications S.A. (IBA), a global leader in particle accelerator technology and nuclear medicine solutions, has signed a multi-site agreement with Shreeji Imaging and Diagnostic Centre Pvt. Ltd. for the delivery and installation of four Cyclone KIUBE 300 cyclotrons in India.
Biotechnology | 21/02/2026 | By Darshana | 394
Newron Strengthens Clinical Development Funding with Multi-Tranche Share Deal
Newron Pharmaceuticals has secured a staged equity financing agreement worth up to EUR 38 million from a consortium of existing and new investors in Europe and Asia, strengthening its balance sheet as it advances late-stage clinical development of evenamide for treatment-resistant schizophrenia.
Biotechnology | 18/02/2026 | By Darshana | 236
Bio-Techne Corporation has received CE-IVD marking for its Ella benchtop immunoassay platform, enabling commercial availability across the European Union and opening new opportunities for clinical diagnostic use.
Biotechnology | 17/02/2026 | By Darshana | 188
Median Technologies, a France-based developer of artificial intelligence-powered software as a medical device, has entered a non-exclusive distribution agreement with Tempus AI, Inc. to commercialise its Eyonis LCS lung screening platform in the United States.
Biotechnology | 15/02/2026 | By Darshana | 361
THX Pharma and Biocodex Sign Licensing Deal for Rare Disease Drug Candidates
Biocodex secures global rights to Batten-1 and North American rights to TX01 from THX Pharma in a deal worth up to Euro 173 million to advance treatments for juvenile Batten disease, Gaucher disease and Niemann-Pick type C.
Biotechnology | 13/02/2026 | By News Bureau | 298
Fujifilm Opens GBP 400 Million UK Biomanufacturing Expansion
Backed by an investment of approximately GBP 400 million from Fujifilm Corporation, the development includes the launch of what the company describes as the UK’s largest single-use biopharmaceutical contract development and manufacturing facility.
Biotechnology | 12/02/2026 | By Darshana | 209
NPPA Directs Drugmakers to Revise MRPs After 2026 Duty Exemptions
The National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to revise the maximum retail prices (MRP) of medicines that received customs duty exemptions under the Union Budget 2026.
Biotechnology | 12/02/2026 | By Darshana | 443
Chugai Exercises Option for AraLinQ Technology in USD 780 Million ADC Collaboration
Chugai Pharmaceutical Co., Ltd. has exercised its option to license Araris Biotech AG’s proprietary AraLinQ linker-payload platform, deepening an existing research collaboration aimed at developing next-generation antibody-drug conjugates (ADCs).
Biotechnology | 11/02/2026 | By Darshana | 270
Lilly’s acquisition of Orna Therapeutics aims to accelerate development of in vivo CAR-T therapies powered by engineered circular RNA and advanced lipid nanoparticle delivery platforms.
Biotechnology | 10/02/2026 | By News Bureau | 310
This collaboration with Frontier Space provides an opportunity for Azenta to demonstrate how its sample management technologies perform in demanding research environments, helping extend use of its high-precision consumables into new research settings and next-generation workflows, further reinforcing the company's leadership in sample integrity.
Biotechnology | 10/02/2026 | By News Bureau | 158
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy